Presentation Information

[3P-891]Comparison of ADCC activity between daratumumab and isatuximab in multiple myeloma with varying CD38 expression levels

○Yuto Takahashi1, akihiro Kitadate2, Sayaka Iwama1, Wataru Kuroki2, Sho Ikeda2, Naoto Takahashi2 (1. Dept. of Life Sci., Grad. Sch. of Eng. Sci., Univ. of Akita, 2. Dept. of Hematology, Nephrology, and Rheumatology, Grad. Sch. of Med., Univ. of Akita)

Password required to view

Please enter the password printed on your name card.
Online registrants can download your name card from the account page once payment has been successfully processed.

Comment

To browse or post comments, you must log in.Log in